Navigation Links
UCLA launches first face transplantation program in western US
Date:5/25/2012

The UCLA Health System has launched the UCLA Face Transplantation Program, the first surgical program of its kind in the western United States and one of only a handful in the nation.

"Facial transplantation offers the potential to restore humanity to persons who have suffered the devastating loss of their face," said Dr. Kodi Azari, chief of reconstructive transplantation and associate professor of surgery at the David Geffen School of Medicine at UCLA. "People with massive facial injuries often have trouble breathing, speaking and eating, as well as depression and social isolation. Early surgeries have demonstrated very promising results in improving both appearance and function."

The UCLA face transplantation team recognizes the sensitivity required when it comes to working with patients who have experienced a severe facial disfigurement. Understanding that a person's identity and sense of self are closely tied to their facial appearance, the team will also support the patient's emotional adjustment to their new face after the surgery.

"Our goal in creating this program is to return a sense of normalcy to our patients' lives," said Dr. Reza Jarrahy, surgical co-director of the new program and assistant professor of plastic and reconstructive surgery at the Geffen School of Medicine. "We hope that restoring facial form and function will provide the opportunity for patients to lead productive lives that are not defined or hampered by facial appearance."

UCLA is currently seeking patients willing to participate in a face-transplant clinical trial and to be followed for five years after their surgery.

Candidates for the clinical trial will undergo a thorough evaluation to determine whether they meet the criteria for participation. The evaluation includes a comprehensive medical history, a physical examination, lab tests, X-rays and a psychological exam. Approved participants will be placed on a waiting list unti
'/>"/>

Contact: Roxanne Moster
rmoster@mednet.ucla.edu
310-794-0777
University of California - Los Angeles Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
2. Mayo Clinic launches whole genome breast cancer study
3. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
4. Cell Press launches Enhanced Career Network
5. CDC Launches Graphic Anti-Smoking Campaign
6. Life-saving radio campaign launches in Burkina Faso
7. Springer launches 6 new medical review journals
8. Fogarty Institute for Innovation launches advanced endovascular training fellowship
9. Independent medical device review site Which Medical Device launches new Anaesthetics section
10. NIH launches trials to evaluate CPR and drugs after sudden cardiac arrest
11. Mutated Kras spins a molecular loop that launches pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... In response to the proposed mammography ... (USPSTF), Strategic Radiology® (SR®) fully aligns itself with ... Gynecologists (ACOG), the American College Of Surgeons, Susan ... (ACS), American College of Radiology (ACR), and Society ... screening mammography for women beginning at age 40 ...
(Date:5/4/2015)... For partners who’d like to become parents, Astroglide ... TTC™ (Trying to Conceive) . Unlike traditional lubricants that ... TTC™ is specially formulated to provide a better environment ... Disease Control, an average of one in eight ... pregnancy, and over 7.4 million women have ...
(Date:5/4/2015)... 04, 2015 Fast on the heels ... Trace Amounts, and Allison Folmar, JD, join over 150 ... internationally. , On Sunday, May 24, the conference presents ... possible?" Are you interested in Ryan Hinds' recovery story? ... our war against autism was written by Marcia ...
(Date:5/4/2015)... 2015 “St. Louis has long represented ... the West,” so it is the perfect place for ... Dr. Ben Litalien, Chief Development Officer for Zerorez. ... and will provide veterans with a $10,000 discount on ... to have a number of Military Veterans in its ...
(Date:5/3/2015)... 03, 2015 AvePoint, ... platforms and devices, today announced it is a ... Professionals (IAPP) Asia Privacy Forum, taking place May ... the event, AvePoint will showcase its compliance, risk, ... platforms. , Visit AvePoint for New Solutions ...
Breaking Medicine News(10 mins):Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4
... LOS ANGELES, Sept. 1 Azteca America television network is proud ... Gavin Newsom on the Sept. 1 broadcast of "Issues: Caras ... , , As a self-styled "social liberal and ... healthcare and San Francisco is probably the highest profile city in ...
... 21 hours later with milder heart attacks, study shows , ... at hospital emergency rooms with chest pains can wait as ... electrocardiogram (EKG) shows evidence of a heart attack, a new ... key measures of heart damage and one-month death rates in ...
... , , National Veterans ... WASHINGTON, Sept. 1 More than 120 Veterans from across ... writing or visual arts contests are preparing to attend the National Veterans ... , "The Creative Arts Festival represents the top achievements ...
... ... orthopaedic surgeons Dr. James R. Andrews and Dr. Lonnie Paulos now beginning its second ... Gulf ... Sports Medicine is now providing free orthopaedic exams and assessments to high school ...
... , , , ... American Imaging Management(R) (AIM), an operating subsidiary of WellPoint, Inc. (NYSE: ... industry, today commended articles on diagnostic imaging that appear in the August 27, ... , The article "Exposure to Low-Dose Ionizing Radiation from Medical ...
... to detect the disease while it is still treatable ... say they have found small molecules in the blood ... have diagnostic implications in the future. , Levels of ... from pancreatic cancer, the fourth-leading cancer killer in the ...
Cached Medicine News:Health News:San Francisco Mayor Gavin Newsom Talks About Immigration and Drugs on Azteca America's 'Issues: Caras y Voces' 2Health News:Sometimes Angioplasty Can Wait 2Health News:VA Honors Veterans Who Are Artists, Performers 2Health News:Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 2Health News:Andrews Institute for Orthopaedics and Sports Medicine Now Providing Free Orthopaedic Exams and Assessments on Saturday Mornings to Student Athletes 3Health News:American Imaging Management Reacts to New England Journal of Medicine Articles on Diagnostic Imaging 2Health News:Blood Test May Spot Pancreatic Cancer Early 2
(Date:5/4/2015)... May 4, 2015   Synthetic Biologics, Inc. ... on protecting the microbiome, as well as treating other ... appointed Chief Financial Officer, Treasurer and Secretary effective June ... who will be leaving the Company in May to ... Synthetic Biologics operational, financial and international biotech industry experience, ...
(Date:5/4/2015)... BOULDER, Colo., May 4, 2015  Array BioPharma ... for the third quarter of its fiscal year ... Chief Executive Officer of Array, noted, "With the close ... binimetinib and encorafenib, two innovative oncology products in ... each product in 2016. These transformative transactions have ...
(Date:5/4/2015)... , May 4, 2015 ... has granted an Orphan Drug Designation (ODD) for rimeporide, ... dystrophy (DMD). DMD is a rare, life-threatening disease affecting ... muscle loss. It is the most common and serious ... a selective sodium/proton exchanger type-1 inhibitor, originally developed by ...
Breaking Medicine Technology:Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 2Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 3Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 10EspeRare's Investigational Compound Rimeporide Receives European Orphan Drug Designation in Duchenne Muscular Dystrophy 2
Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml....
1.0% Tryptone, 0.5% yeast extract, 0.5% Sodium Chloride, 1.5% agarose....
1% tryptone, 0.5% yeast extract, 1.0% Sodium Chloride, 1.5% agar....
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Medicine Products: